Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum
スポンサーリンク
概要
- 論文の詳細を見る
- 2006-03-01
著者
-
Kano Masanobu
Department Of Cellular Neurophysiology Graduate School Of Medical Science Kanazawa University
-
Hashimoto Kouichi
Department Of Cellular Neuroscience Graduate School Of Medicine Osaka University
-
Hashimoto Kouichi
Department Of Cellular Neurophysiology Graduate School Of Medical Science Kanazawa University
-
NARUSHIMA Madoka
Department of Cellular Neurophysiology, Graduate School of Medical Science, Kanazawa University
-
Narushima Madoka
Department Of Cellular Neurophysiology Graduate School Of Medical Science Kanazawa University
-
Hashimoto Kouichi
Department of Biotechnology and Life Science, Graduate School of Engineering, Tokyo University of Agriculture and Technology
関連論文
- A novel action of stargazin as an enhancer of AMPA receptor activity
- Effects of C/Si Ratio in Chemical Vapor Deposition of 4H-SiC(1120) and (0338)
- Metabotropic glutamate receptor subtype-1 is essential for motor coordination in the adult cerebellum
- Endogenous cannabinoid as a retrograde messenger from depolarized postsynaptic neurons to presynaptic terminals
- Plasticity of inhibitory synapses in the brain: a possible memory mechanism that has been overlooked
- Motor discoordination of transgenic mice overexpressing a microtubule destabilizer, stathmin, specifically in Purkinje cells
- Roles of Endocannabinoids in Modulation of Synaptic Transmission
- Heterosynaptic expression of depolarization-induced suppression of inhibition (DSI) in rat hippocampal cultures
- Endocannabinoid-mediated short-term suppression of excitatory synaptic transmission to medium spiny neurons in the striatum
- Postnatal development and synapse elimination of climbing fiber to Purkinje cell projection in the cerebellum
- Autologous CTL response against cancer stem-like cells/cancer-initiating cells of bone malignant fibrous histiocytoma
- ISP-3-2 Treatment patterns and prognosis of stage 2b cervical cancer(Group 3 Oncology 3,IS Poster,International Session)